IBX 2.17% 4.7¢ imagion biosystems limited

Going Concern - Auditors, page-2

  1. 174 Posts.
    lightbulb Created with Sketch. 26
    So the Auditors flagged the company's 2022 funding (1/1/2022 to 21/12/2022) as a KAM in the Auditor's Report for the year ended 31/12/2021.

    They gave the company a tick for sufficient funding being in place up to 31/12/2022, I assume following representations made by the company.

    But I'm interested in funding for the the year ending 31/12/2023.

    I assume that the Auditors will be looking closely at the company's 2022 accounts for reasonable assurance that funding for the following twelve months (1/1/2023 to 31/12/2023) will be in place.

    I've heard nothing from the company about funding initiatives for 1/1/2023 to 31/12/2023.

    Does anyone have information on funding for the the year ending 31/12/2023? Possibly a CR or an equity partner or some other form of funding?

    And would a CR be successful?

    I'm not skilled in this field and this is not financial advice. Please do your own research.

    Regards
    Stretguy.


 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
4.7¢
Change
0.001(2.17%)
Mkt cap ! $2.022M
Open High Low Value Volume
4.7¢ 4.7¢ 4.7¢ $294 6.25K

Buyers (Bids)

No. Vol. Price($)
1 41666 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 20000 1
View Market Depth
Last trade - 10.17am 13/11/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.